Showing results (31-40 of 466) with videos related to
Sort By:
Pageof 47
Annals of Internal Medicine|January 22, 2000
Acquired C1 esterase inhibitor deficiencyS N Markovic, D J Inwards, E A Frigas, et al.Leukemia|November 5, 2004
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myelomaA Dispenzieri, G A Wiseman, M Q Lacy, et al.Leukemia|December 24, 2011
Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whitesA J Greenberg, C M Vachon, S V RajkumarMayo Clinic Proceedings|June 11, 1998
Diagnostic value of albumin gene expression in liver tumors: case report and review of the literatureS V Rajkumar, R L Richardson, J R GoellnerThe American Journal of Medicine|April 29, 1998
Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathyS V Rajkumar, M A Gertz, R A KyleCancer|April 29, 1998
Primary systemic amyloidosis with delayed progression to multiple myelomaS V Rajkumar, M A Gertz, R A KyleLeukemia|August 2, 2001
Thalidomide for previously untreated indolent or smoldering multiple myelomaS V Rajkumar, A Dispenzieri, R Fonseca, et al.American Journal of Hematology|January 5, 2002
Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantationS V Rajkumar, R Fonseca, A Dispenzieri, et al.The American Journal of Surgical Pathology|November 14, 1997
Malignant lymphoma of the bladder: evidence from 36 cases that low-grade lymphoma of the MALT-type is the most common primary bladder lymphomaC L Kempton, P J Kurtin, D J Inwards, et al.Bone Marrow Transplantation|July 22, 1999
Autologous stem cell transplantation for relapsed and primary refractory myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.Pageof 47